IRIS
MEDAGLINI, DONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.556
EU - Europa 9.139
AS - Asia 5.361
SA - Sud America 916
AF - Africa 308
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 26.313
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.357
RU - Federazione Russa 2.006
SG - Singapore 1.722
CN - Cina 1.694
GB - Regno Unito 1.499
IT - Italia 1.382
IE - Irlanda 1.197
BR - Brasile 739
SE - Svezia 655
VN - Vietnam 586
DE - Germania 576
UA - Ucraina 521
FR - Francia 484
HK - Hong Kong 442
FI - Finlandia 411
KR - Corea 288
ZA - Sudafrica 181
IN - India 161
CA - Canada 114
BD - Bangladesh 111
ES - Italia 73
NL - Olanda 65
PL - Polonia 56
AR - Argentina 53
MX - Messico 45
IQ - Iraq 40
JP - Giappone 40
NG - Nigeria 40
TR - Turchia 39
UZ - Uzbekistan 38
BE - Belgio 33
AT - Austria 32
VE - Venezuela 27
PK - Pakistan 25
EC - Ecuador 23
ID - Indonesia 23
CH - Svizzera 22
CL - Cile 19
CZ - Repubblica Ceca 19
AU - Australia 18
LT - Lituania 18
CI - Costa d'Avorio 17
KE - Kenya 16
CO - Colombia 14
IR - Iran 14
SA - Arabia Saudita 14
EG - Egitto 13
MA - Marocco 13
MY - Malesia 13
GR - Grecia 11
IL - Israele 11
PE - Perù 11
PH - Filippine 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
BO - Bolivia 9
JO - Giordania 9
NP - Nepal 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
EU - Europa 8
PT - Portogallo 8
UY - Uruguay 8
AZ - Azerbaigian 7
CR - Costa Rica 7
OM - Oman 7
SI - Slovenia 7
ET - Etiopia 6
RS - Serbia 6
TH - Thailandia 6
BG - Bulgaria 5
JM - Giamaica 5
MD - Moldavia 5
PA - Panama 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
DZ - Algeria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
LK - Sri Lanka 4
MT - Malta 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
EE - Estonia 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
LV - Lettonia 3
PS - Palestinian Territory 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
GT - Guatemala 2
Totale 26.273
Salva come PNG Salva come JPEG
Città #
Dallas 1.404
Southend 1.198
Dublin 1.193
Singapore 935
Fairfield 889
Ashburn 871
Chandler 678
Moscow 540
Santa Clara 528
San Jose 433
Hong Kong 417
Jacksonville 416
Woodbridge 399
Beijing 396
Siena 367
Hefei 335
Houston 331
Seattle 329
Wilmington 312
Cambridge 297
Seoul 280
Ann Arbor 246
Helsinki 219
Los Angeles 208
Princeton 198
Munich 176
The Dalles 163
Johannesburg 161
New York 161
Milan 156
Ho Chi Minh City 137
Nanjing 134
Hanoi 132
Lauterbourg 129
Council Bluffs 124
Dong Ket 121
Florence 112
Rome 83
Lappeenranta 73
San Mateo 73
Boardman 69
São Paulo 68
San Diego 66
Buffalo 63
Shanghai 60
Lancaster 59
Orem 54
Shenyang 49
Menlo Park 48
London 46
Frankfurt am Main 44
Nanchang 41
Nuremberg 41
Turku 40
Bengaluru 38
Redondo Beach 38
Tokyo 38
Abuja 37
Montreal 37
Chicago 35
Toronto 35
Columbus 34
Chennai 33
Denver 33
Brussels 31
Tashkent 31
Dearborn 30
Phoenix 30
Warsaw 30
Amsterdam 29
Tianjin 28
Málaga 27
San Francisco 27
Düsseldorf 25
Kunming 25
Washington 25
Da Nang 23
Hebei 23
Belo Horizonte 22
Guangzhou 22
Haiphong 22
Jiaxing 22
Brooklyn 21
Fremont 21
Poplar 20
Rio de Janeiro 19
Abidjan 17
Atlanta 17
Norwalk 17
Changsha 16
Stockholm 16
Madrid 15
Messina 15
Mumbai 15
Piscataway 15
Redwood City 15
Zhengzhou 15
Baghdad 14
Dhaka 14
Jinan 14
Totale 17.228
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 356
13C-NMR determination of simultaneous xylose and glucose fermentation by a newly isolated strain (G11) of Klebsiella planticola 339
Vaginal immunization to elicit primary T-cell activation and dissemination 331
A stochastic model for CD4+ T cell proliferation and dissemination network in primary immune response 314
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 312
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 305
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 304
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 303
Vaccination in the elderly: The challenge of immune changes with aging 300
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 292
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 290
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 288
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 288
Ebola vaccine R&D: Filling the knowledge gaps 281
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine 277
Adoptive transfer of transgenic T cells to study mucosal adjuvants 275
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 274
Correlates of vaccine-induced protective immunity against Ebola virus disease 273
Identification of a branching process model for adaptive immune response 263
Role of the microbiota in the modulation of vaccine immune responses 262
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells 258
Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae 256
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 253
Big science for vaccine development 253
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 246
Assessment of mucosal immunity to HIV-1 242
Modulation of Primary Immune Response by Different Vaccine Adjuvants 233
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 231
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 227
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 218
Biotechnological approaches to fight pathogens at mucosal sites 218
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts 212
Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface 212
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 210
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 208
ADITEC: joining forces for next-generation vaccines 207
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 206
The European research effort for HIV/AIDS, malaria and tuberculosis 205
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 205
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 204
Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii 203
Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii 203
Recombinant Gram-positive bacteria as vehicles of vaccine antigens 202
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 201
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 201
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 195
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 195
Vaccine adjuvants: A priority for vaccine research 194
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 193
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 192
O:2-CRM(197) Conjugates against Salmonella Paratyphi A 192
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 192
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 190
La diagnosi eziologica della polmonite comunitaria: possibile ruolo della Real-Time PCR in una coorte di pazienti adulti e pediatrici 190
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 188
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 187
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 187
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 186
Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii 185
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 185
Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis 182
Physicochemical characterization cascade of nanoadjuvant–antigen systems for improving vaccines 181
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 180
The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 180
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols 179
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 176
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 176
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 175
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 175
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 175
Primary T-cell response to mucosal vaccination 174
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 174
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 174
Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice 173
Gram-positive commensal bacteria for mucosal vaccine delivery. 173
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 171
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 171
Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium 170
Innate immunity against HIV: a priority target for HIV prevention research 168
Immunogenicity of a bivalent adjuvanted glycoconjugate vaccine against Salmonella typhimurium and Salmonella Enteritidis 167
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 166
Surface display of recombinant proteins on Bacillus subtilis spores 164
Impact of interproximal composite restorations on periodontal tissue health: Clinical and cytokine profiles from a pre-post quasi-experimental study 164
In vivo mucosal delivery of bioactive human interleukin 1 recepor antagonist produced by Streptococcus gordonii 163
Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii 163
The European effort towards the development of mucosal vaccines for poverty-related diseases 163
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 161
Vaginal immunization with recombinant gram-positive bacteria 160
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 160
NMR Investigation of the Simultaneous Fermentation of Xylose and Glucose by a Selected Strain of Klebsiella Planticola (G11) 159
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 157
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 157
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 157
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 157
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 156
Recombinant Streptococcus gordonii as live vehicle for vaccine antigens. 155
Editorial: Advanced Immunization Technologies for Next Generation Vaccines 155
Expression of measles virus antigens in Streptococcus gordonii 154
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 153
Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens 152
Totale 20.962
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 0 0 209
2021/20221.590 117 225 97 159 64 27 85 53 83 142 184 354
2022/20232.352 146 238 317 305 212 463 61 205 181 49 118 57
2023/20242.022 72 67 160 118 79 518 665 65 43 87 35 113
2024/20254.385 129 179 428 248 535 278 204 263 435 180 422 1.084
2025/20269.794 779 1.459 1.038 1.217 1.838 356 1.044 382 473 621 368 219
Totale 26.625